Table 3.
Clinical characteristics of four patients with excessive sleepiness after COVID-19 infection
| Case one | Case two | Case three | Case four | |
|---|---|---|---|---|
| Sex | F | M | F | F |
| Age (years) | 35 | 42 | 32 | 55 |
| Time from COVID-19 infection (months) | 18 | 18 | 13 | 18 |
| Need for hospitalization | N | N | N | N |
| Cognitive complaint | Y | Y | Y | Y |
| Time from ES onset (months) | 17 | 17 | 12 | 17 |
| Epworth scale | 22 | 16 | 21 | 4 |
| Snoring | N | N | N | N |
| Fatigue | Y | N | Y | N |
| Restorative sleep | N | N | N | N |
| Cataplexy | N | N | N | N |
| RLS symptoms | N | N | N | N |
| Treatment | Modafinil 200 mg/d + Methylphenidate 10 mg/d | Modafinil 200 mg/d | Lisdexamphetamine 35 mg/d | – |
| Improvement of ES | Y | Y | Y | Y |